Document is current
Any future updates will be listed below
-
Authors
Le Corvec, Maëna
Farrugia, Marwin A.
Nguyen-Khac, Eric
Régimbeau, Jean-Marc
Dharhri, Abdennaceur
Chatelain, Denis
Khamphommala, Litavan
Gautier, Anne-Lise
Le Berre, Nathalie
Frey, Sébastien
Bronowicki, Jean-Pierre
Brunaud, Laurent
Maréchal, Chloé
Blanchet, Marie-Cécile
Frering, Vincent
Delwaide, Jean
Kohnen, Laurent
Haumann, Alexandre
Delvenne, Philippe
Sarfati-Lebreton, Marine
Tariel, Hugues
Bernard, Jérôme
Toullec, Alexis
Boursier, Jérôme
Bedossa, Pierre
Gual, Philippe
Anty, Rodolphe
Iannelli, Antonio
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03978247 at ClinicalTrials.govDocuments that mention this clinical trial
Blood-based MASH diagnostic in candidates for bariatric surgery using mid-infrared spectroscopy: a European multicenter prospective study
https://doi.org/10.1038/s41598-024-72704-5
-
Funding
Funding for this research was provided by:
Institut National de la Santé et de la Recherche Médicale
LABEX SIGNALIFE (#ANR-11-LABX-0028-01)
Université Côte d’Azur
Agence Nationale de la Recherche (#ANR-15-IDEX-01)
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 10 September 2024
First Online: 2 November 2024
Competing interests
: Maëna Le Corvec and Alexis Toullec were DIAFIR employees; Jérôme Bernard was the DIAFIR General Manager for Healthcare; Hugues Tariel is the DIAFIR Chief Executive Officer. All the remaining authors declare no conflict of interest.
